AbbVie in advanced talks to buy cancer drugmaker revolution medicines, shares jump nearly 30%
Published on: Jan. 8, 2026, 3:35 a.m. | Source: The Economic Times
AbbVie is in advanced talks to buy Revolution Medicines, a cancer drug company. The news pushed Revolution Medicines shares sharply higher. Investors see the deal as a growth move for AbbVies cancer business. The possible acquisition supports AbbVies plan to replace revenue lost after Humira patents expired and strengthen its future drug pipeline.
